Frauke Schnorfeil

Frauke Schnorfeil has a substantial work experience in the field of science and research. Frauke started their career as a PhD student at the Institut für Immunologie, Klinikum der Universität München in 2007 and completed their tenure in 2011. Frauke then joined the Clinical Cooperation Group Immunotherapy, Helmholtz Zentrum München as a Postdoctoral Researcher and worked there until 2015. Following that, they joined the Klinikum der Universität München as a Medical Scientist from 2015 to 2018.

In 2019, Frauke Schnorfeil moved to Medigene AG and served as a Senior Scientist until 2020. Frauke then joined PPD in 2021 as a Country Approval Specialist, where they worked until 2022. Currently, in 2022, they are employed as a Senior Scientist at Bavarian Nordic.

Throughout their career, Frauke Schnorfeil has gained extensive expertise in various scientific research roles, showcasing their dedication and commitment in the field of science.

Frauke Schnorfeil completed their education from 2000 to 2006 at Ludwig-Maximilians-Universität München, where they earned a Diplom degree in Biology. Frauke then pursued further studies at the University of Leicester in the Department of Infection, Immunity, and Inflammation, although the specific degree obtained is unknown. In addition to their formal education, Frauke Schnorfeil obtained certifications in Projektmanagement in klinischen Prüfungen through seminars and workshops organized by FORUM Institut für Management GmbH in December 2020.